Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
FXR modulators for enterohepatic and metabolic diseases
HTML
Details
Locations
Year:
2018
Type:
review
Source:
Expert Opinion on Therapeutic Patents
DOI:
10.1080/13543776.2018.1527906
Authors:
Hong Wang,
Qingxian He,
Guangji Wang,
Xiaowei Xu,
Haiping Hao
Institutions:
China Pharmaceutical University,
State Key Laboratory of Natural Medicine
Language:
English
Topic:
Drug Transport and Resistance Mechanisms
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
farnesoid X receptor,
metabolic disorders,
bile acid homeostasis,
lipid homeostasis,
glucose homeostasis,
obeticholic acid,
pruritus,
FXR agonists,
FXR antagonists,
obesity,
inflammation,
fibrosis,
cancer
show all 13
SDG:
Good health and well-being
Open Access status:
closed
Funders:
National Natural Science Foundation of China,
China Postdoctoral Science Foundation,
Overseas Expertise Introduction Project for Discipline Innovation
Awards:
G1289390747,
G18930282,
G307300976,
G4489372624,
G5694733058,
G6087836920,
G6436905974,
G773098901,
中药复杂组群代谢与药效机制桥接新理论及方法研究,
中药体内“三维药效物质基础”理论与方法学研究
show all 10
OpenAlex ID:
W2893514707
FWCI:
0.787
Cites:
113
Cited by:
94
Related to:
10